The bullish trend remains unchanged; we remain bullish on gold.#XAUUSD OANDA:XAUUSD TVC:GOLD
The daily chart is above the MA5 moving average, indicating that the bullish trend remains unchanged. However, we do not chase the price at high levels. Our core strategy is to wait for a pullback to support before going long. From the hourly chart, gold is fluctuating within the 4220-4180 range in the short term. If gold retraces to the short-term support of 4190-4180 during the European session, it is advisable to continue to go long on gold, with key support at 4160-4150. If the price rebounds to the previous high of 4250-4260, then yesterday's strategy remains valid.
Search in ideas for "MOVING AVERAGE"
Brent Oil Under Pressure – Key Resistance Zone Holding Strong!🔥 UKOIL / BRENT Energies Market Opportunity Blueprint (Day & Swing Plan) ⚡️
📉 Plan Overview:
Thief is spotting a Bearish Blueprint on UKOIL / Brent — price confirming rejection around the Triangular Moving Average (TMA) zone 📊. A clean pullback and retest structure are forming — time for a layered sell approach to capitalize on energy market volatility ⚙️
🎯 Entry Idea:
Thief enters with multiple limit layers (Layering Strategy) — scaling in smartly with precision entries:
🔹 Sell Limits @ 64.500 / 64.000 / 63.500
(You can increase or adjust the layers based on your own conviction & market timing 🕰️)
🛑 Stop-Loss Guidance:
This is Thief’s SL @ 65.000 💣
Dear Ladies & Gentlemen (Thief OG’s), adjust your stop loss based on your risk appetite and confirmation setups. Risk management is the crown 👑 of consistency.
💰 Target Zone:
Watch out for the Police Barricade Zone @ 60.500 — this level aligns with strong support, potential oversold condition, and a trap + correction scenario 🔦
Escape with profits before liquidity hunts you — take money when you see money 💵
📘 Note to Thief OG’s:
I’m not recommending my SL or TP as mandatory levels — it’s your chart, your strategy, your risk, your reward. Trade smart, not emotional 🧠
🧩 Related Market Pairs to Watch:
🔸 WTI Crude (USOIL/USD) – Highly correlated with UKOIL. A bearish structure here often confirms momentum for Brent.
🔸 USD/CAD 💵 – Inverse correlation! A rising USD/CAD often strengthens the bearish sentiment in crude markets.
🔸 XLE (Energy ETF) – Keeps track of energy sector performance; confirmation of trend strength adds confluence to your trade.
📊 Key Market Correlations:
Oil reacts strongly to USD strength, global demand outlook, and OPEC sentiment. Keep an eye on DXY (US Dollar Index) — stronger dollar usually pressures Brent prices lower 💹
🚀 Thief Quote of the Day:
"Patience pays more than panic — layer in silence, exit in profit." 🕶️
#UKOIL #Brent #EnergyMarket #ThiefTrader #BearishSetup #LayeringStrategy #SwingTrade #OilMarket #WTI #USD #Commodities #TechnicalAnalysis
Gold - Shorts - Historical proof🟠 How Traders Could Interpret the Orange Candles
(Price-Action Only )
The orange candles highlight moments where the selling pressure becomes unusually strong during a clear downward environment. You don’t need to know any internal calculations — the chart already shows the important context visually.
Here’s how users could have read these moments, purely from the candles and the structure around them:
🟠 1. Each orange candle appears during a strong push downward
On all the marked spots, you can visually see:
A large bearish candle compared to surrounding candles
A clear downward close
Momentum accelerating in the direction the market was already moving
This makes the orange candles easy to understand visually:
They highlight strong bearish expansion inside an already bearish swing.
📉 2. They show momentum continuation, not reversal signals
Looking at the chart:
Before each orange candle → price is already moving down.
After each orange candle → price continues lower or forms another push down.
So visually, the candles reinforce the idea that the market is pushing with renewed strength, not hesitating.
Traders often view this kind of candle as a sign that sellers have stepped in aggressively again.
🧱 3. How many price-action traders might visually use them
(Purely descriptive — NOT trading advice.)
When an orange candle appears:
The market is visibly trending downward.
A large bearish candle forms.
The momentum aligns with the direction of the trend.
A trader might visually interpret this as:
“The sellers are clearly in control again. If price continues downward on the next bar, this could be a continuation of the trend.”
Again: this is not a buy/sell instruction, just an explanation of how chart readers typically interpret strong candles within a trend.
🔎 4. Visual walk-through of the chart you provided
🟠 First orange candle (far left)
Appears after a small pullback upward.
The market prints a strong bearish candle, visually showing that the pullback has ended and downside momentum is returning.
Price continues lower afterward.
🟠 Middle orange candles
These show up repeatedly after small sideways pauses.
Each one marks a moment where sellers regain control and push the market.
After the orange bars, the trend resumes downward.
🟠 Final orange candle (far right)
Appears as price attempts to rise but fails.
The orange candle shows a strong downward rejection.
Trend continues in the same direction after.
Nothing in this interpretation relies on knowing your moving averages, ATR usage, filters, or thresholds — everything is visible on the chart.
📘 5. Important wording
This does not indicate or recommend trades.
The orange bars simply highlight visually strong bearish expansion within the current structure.
How a trader reacts to them is entirely up to their own system, rules, and risk management.
GER40 INSTITUTIONAL ACCUMULATION PHASE: 📊 GER40 INSTITUTIONAL ACCUMULATION PHASE: Breakout Architecture & Supply Zone Defense - November 13, 2025
Asset: GER40 (DAX CFD Spot) | Current Level: 24,475 | Analysis Date: Nov 13, 2025 | Market Condition: Bull Continuation Setup
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🔍 STRUCTURAL TREND FRAMEWORK
Sequential price action demonstrates consistent markup pattern across timeframe hierarchy. Bullish structure remains robust with price stabilization above the 200-period simple moving average confirming ongoing accumulation cycle. Support-level rejections exhibit strong demand absorption - upward participation bias exceptionally high.
📍 PATTERN RECOGNITION ARCHITECTURE
5-Min Zone: Ascending pennant nearing apex - directional breakout probability elevated
Quarter-Hour Interval: Bullish wedge consolidation - upper band penetration signals continuation
30-Min Structure: Inverted formation resembling cup build with handle positioning near key level
Hourly Context: Rectangular consolidation box - breakout vector pointing skyward
4-Hour Viewpoint: Reverse shoulder-head-shoulder formation with neckline action pending
⚙️ QUANTITATIVE INDICATOR MATRIX
Momentum Gauge: 4H oscillator range 63-68 (sustained positive momentum, non-stretched extremes)
Bollinger Band Position: Price action above centerline on 1H - volatility expansion pattern emerging
Moving Average Stack: 20-period > 50-period > 200-period (Golden Cross architecture established)
Volume-Weighted Benchmark: Price deployment above daily volume-weighted average confirms buyers in control
Cloud Formation: Senkou alignment favoring upside - Leading Span B crossed above Span A
🎯 EXECUTION FRAMEWORK & SCENARIOS
DOMINANT BULLISH SCENARIO:
Activation Trigger: Hourly candle closure exceeding 24,080 with intraday volume acceleration
Price Objectives: 24,175 (R1) → 24,245 (R2) → 24,330 (Weekly Apex)
Downside Guard: Stop placement below 24,000 (Triple formation base breach)
CONTINGENCY BEARISH SCENARIO:
Trigger Point: Failure from 24,105 + Closing below 4H support + Volume washout
Target Zones: 23,980 → 23,900
Protective Stop: Above 24,150
🔑 PRICE LEVEL HIERARCHY
Resistance Cluster: 24,105 | 24,175 | 24,245 | 24,330
Support Foundation: 24,015 | 23,980 | 23,900
📐 HARMONIC & CYCLICAL MECHANICS
Geometric pattern analysis identifies potential Gartley structure approaching completion - asymmetric retracement zones suggesting reversal environment. Angular analysis from cyclical lows validates ascending trajectory with structural integrity intact through geometric resistance markers.
✅ DECISION CRITERIA CHECKLIST
Bullish Confirmation Criteria: Volume bar expansion | Hourly close above threshold | Oscillator non-divergence
⚠️ Risk Disclosure: Analysis provided for educational framework only. Position management and capital preservation via stop-loss implementation remain trader responsibility. Market dynamics subject to instantaneous regime change.
Going long on multi-core logicCore Logic for Going Long: Three-Dimensional Resonance Lays the Foundation for Growth
1. Capital Aspect: ETF Outflows Near an End, with Solid Institutional Core Positions
Bitcoin spot ETFs recorded a net outflow of $2.7 billion in the past month, yet this only accounted for 1.5% of the total assets under management, with 98.5% of the capital remaining held. This indicates that the pressure from short-term capital outflows is drawing to a close. Judging from historical patterns, such a volatile growth trend featuring "two steps forward and one step back" is usually followed by capital inflows. Meanwhile, enterprises including MicroStrategy and Metaplanet keep increasing their Bitcoin holdings. BlackRock is expanding its spot ETF layout in Canada, and institutional demand for long-term allocation remains unabated, providing fundamental support for Bitcoin's price.
2. Macroeconomic Policies: Rate Cut Expectations Recover, Loose Liquidity on the Horizon
Although the Federal Reserve has implemented two consecutive interest rate cuts before and Powell released hawkish signals, the market still expects a 60% probability of another rate cut in December. Currently, inflation has fallen to 3.2%, creating room for further easing of monetary policy. Moreover, Bitcoin, with a high correlation coefficient of 0.77 with the Nasdaq 100 Index, will simultaneously benefit from the improvement in macro liquidity. In addition, expectations for crypto-friendly policies continue to build momentum, and the potential clarification of regulatory frameworks will further boost market confidence.
3. Technical Aspect: Oversold Rebound Signals Emerge, with Effective Support in the Volatile Range
On the daily timeframe, Bitcoin has stabilized and rebounded above the $100,000 mark. The $102,100 level, located at the lower edge of the previous volatility mid-range, boasts strong support characteristics. The 4-hour chart shows that the price has returned to the middle band of the Bollinger Bands. The RSI indicator has recovered from the oversold zone, and the green bars of the MACD have been continuously narrowing, indicating a gradual exhaustion of bearish momentum. Meanwhile, although the 20-day, 50-day, and 100-day moving averages have formed a cluster of short-term resistance levels, the price gap between the current price and these resistance levels leaves ample room for speculation regarding a rebound.
Bitcoin trading strategy
buy:101000-102000
tp:103000-104000
sl:99500
Last Cycle Push - Incoming Breakout?If BTC maintains above the 50 moving average on the weekly, then we should be looking for a final push to the upside to end the bullish cycle. We are given a falling wedge formation in the daily timeframe. There is also plenty of room for development on the oscillators.
XAUUSD: Gold is going to hit $5,000 USD. 1. Uptrend Confirmation:
• After a period of correction/sideways movement (from around mid-October to early November), the recent Heikin Ashi candles have started turning green/bullish (corresponding to the dark green color in your target zone).
• The green candle bodies are lengthening and have short or non-existent lower wicks, which is a classic sign of a strong and sustainable uptrend on a Heikin Ashi chart.
2. Short-term Resistance Breakout:
• The current price ($4,087.880) has broken above the previous short-term resistance area (the red line and the price zone around $4,003.410 - $4,091.265), and is above the moving averages (EMAs - the thin red and green lines), indicating that buying pressure has taken control.
3. Buy Trade Setup (Long Position):
• The chart shows a BUY trade setup with an entry price within the $4,091.265 region.
• Take Profit (TP) Target: Set at a very high level, $4,987.515. This implies an extremely strong expectation for price appreciation, possibly based on extended analysis (Fibonacci Extension) or large institutional price forecasts.
• Stop Loss (SL) Level: Set at $4,003.410, just below the old support/resistance zone, demonstrating clear risk control.
Bearish bar signals risk of deeper crude slideUnable to climb above the 50-day moving average and having just delivered an almighty bearish bar, is WTI crude about to revisit the October lows—an outcome that could put a retest of the YTD lows on the cards? With momentum indicators like RSI (14) and MACD swinging sharply lower, signaling building downside strength, the risk of such a move is growing.
$58.00 is a minor level to watch near term, having acted as support and resistance at times last month. Should price trade beneath this level, shorts could be established on the break with a stop above for protection, targeting a run toward the October swing low of $56.00. The preference would be to see a back-test and rejection of the level before entry.
While short setups are favored given recent price and momentum signals, should WTI manage to hold above $58.00 during Thursday’s session, the option would be there to flip the setup, allowing for longs with a stop beneath for protection. $60.00 screens as an appropriate initial target, even with the messy price action around it recently.
Plenty of fundamental catalysts were bandied around to explain Wednesday’s abrupt drop, most linked to an EIA report warning of market oversupply. It undoubtedly contributed to the bearish move, but the seeds were sown well before the event given how poorly WTI traded at the 50DMA in recent weeks.
Good luck!
DS
Insight Enterprises | NSIT | Long at $92.10Insight Enterprises NASDAQ:NSIT
Technical Analysis
Price entered my "crash" simple moving average zone. Often, but not always, this is an area of algorithmic share accumulation and price reversal. A red flag, however, is that there are still open price gaps on the daily chart down to $50. A green flag is that there are open price gaps up to $215. While the price gaps below will likely get filled in the future, I am betting on a short-term reversal (if not longer-term one) given the prospective growth and its current P/E of 20x (electronic industry currently near 30x).
Insight AI
Stock enters the "crash" zone, and suddenly there is an generative AI announcement to drive revenue and EPS growth: www.businesswire.com . Intentional drive down of stock price for entry? Time will tell.
Revenue and Earnings-per-Share Growth into 2028
Revenue: $8.32 billion in 2025 to $9.88 billion in 2028 (+10.8%)
EPS: $9.64 in 2025 to $12.38 in 2028 (+28.4%)
Health
Debt-to-Equity: 0.9x (pretty good)
Quick Ratio / ability to pay current bills: 1.3 (1.5-3.0 is ideal, but still pretty good)
Alman's Z Score / risk of bankruptcy: 1.8 (3+ is ideal, so moderate risk)
EBIDTA: 5% to 7% range, which is generally considered healthy
Action
Given the "value", AI integration, technical analysis assessment, and growth, NASDAQ:NSIT is in a personal buy zone at $92.10. Caution if the stock dead-cat bounces and aims to drop further into the $50s, but I suspect fundamentals will have to dramatically change in the near-term for that to happen (or the economy crashes)...
Conservative Targets into 2028
$105.00 (+14.0%)
$117.00 (+27.0%)
Bitcoin Reversal Signals Emerge on Momentum IndicatorsIntroduction
GoldmanPeak reviews the latest developments in Bitcoin’s technical structure as key momentum indicators begin to suggest potential reversal signals following weeks of subdued trading. The cryptocurrency has shown early signs of regaining strength after stabilizing near medium-term support zones, with incremental buying pressure emerging in response to improving liquidity depth and positive funding normalization. Market participants are increasingly monitoring these subtle shifts, as technical confirmation could mark a transition from consolidation toward renewed directional activity.
The broader digital-asset market reflects a cautious but improving sentiment. GoldmanPeak reviews that traders have shifted from defensive positioning to selective accumulation, guided by quantitative models signaling relative strength recovery. This behavior highlights Bitcoin’s evolving role as both a risk proxy and a liquidity anchor within the global financial landscape. While volatility remains constrained, the convergence of technical momentum and liquidity expansion suggests a potential inflection point that may redefine short-term trading dynamics.
Technology & Innovation
Technological advancement remains the foundation of analytical precision in digital-asset markets. GoldmanPeak reviews that algorithmic trading systems and AI-enhanced data engines are now central to identifying and confirming market reversals. Advanced models integrate oscillatory analysis—tracking indicators such as moving average convergence divergence (MACD), stochastic momentum, and RSI divergence—to assess whether Bitcoin’s current stabilization phase aligns with the early stages of trend reversal.
Machine learning has elevated the speed and reliability of market interpretation. Neural networks can now process millions of data points across exchanges, evaluating liquidity density, order-book imbalances, and on-chain flows simultaneously. GoldmanPeak reviews how these systems translate fragmented data into actionable insights, identifying micro-patterns that precede directional shifts. The ability to detect anomalies before they manifest in price movements has redefined short-term strategy calibration for both institutional and algorithmic traders.
Moreover, blockchain-integrated analytics platforms are advancing transparency and execution efficiency. By combining smart-contract auditing with AI-driven liquidity mapping, traders can assess real-time depth and volatility conditions across multiple venues. GoldmanPeak reviews that these innovations create a more synchronized and responsive trading environment. The intersection of artificial intelligence, decentralized infrastructure, and market analytics has allowed Bitcoin’s price discovery process to become more data-driven, mitigating the emotional volatility that historically characterized the asset.
Growth & Adoption
The resilience of the Bitcoin ecosystem continues to attract steady participation from both institutional and retail investors. Despite extended periods of range-bound behavior, engagement metrics remain robust across major trading venues. GoldmanPeak reviews that exchange volumes, derivative open interest, and transaction frequency indicate sustained confidence in Bitcoin’s long-term trajectory. This consistent participation reflects a maturing market less influenced by speculation and more guided by structured analysis and diversified portfolio integration.
Institutional adoption continues to expand through new custodial solutions, risk-adjusted products, and AI-assisted portfolio strategies. GoldmanPeak reviews that institutions increasingly rely on algorithmic optimization tools that rebalance Bitcoin exposure in response to changing volatility regimes. This data-centric approach has reduced the impact of abrupt price swings while improving capital efficiency. Simultaneously, retail investors benefit from improved user interfaces, transparent fee structures, and advanced risk dashboards that mirror institutional-grade analytics.
Beyond trading activity, the broader adoption landscape highlights Bitcoin’s growing utility within financial infrastructure. The asset’s integration into payment networks, decentralized liquidity pools, and cross-border settlement systems reinforces its foundational role in the digital economy. GoldmanPeak reviews that even in consolidation phases, Bitcoin continues to expand in function and relevance, demonstrating the structural durability that underpins its global acceptance.
Transparency & Risk Management
As digital markets evolve, transparency and risk discipline remain essential to sustainable growth. GoldmanPeak reviews that exchanges and liquidity providers have intensified their focus on verifiable transparency mechanisms, including on-chain proof-of-reserves, audited solvency reports, and automated data disclosures. These measures enhance investor trust and promote operational accountability, ensuring that liquidity inflows are supported by credible governance structures.
AI-driven risk frameworks are now integral to real-time market surveillance. Automated systems monitor leverage concentration, counterparty exposure, and liquidation probabilities, offering early warnings before stress conditions escalate. GoldmanPeak reviews that this proactive approach has transformed crypto market management—minimizing disorderly moves and promoting stability during periods of uncertainty. By employing predictive analytics to assess liquidity shocks, modern platforms have strengthened market resilience and improved investor confidence.
Additionally, advancements in compliance automation have aligned the digital-asset ecosystem with traditional regulatory standards. Continuous reporting protocols, transaction screening, and adaptive capital thresholds ensure that platforms maintain both transparency and operational efficiency. GoldmanPeak reviews that this alignment signals an industry-wide shift toward long-term credibility, where risk control mechanisms evolve alongside innovation rather than in opposition to it.
Industry Outlook
From an industry perspective, Bitcoin’s current technical setup represents a pivotal juncture between consolidation and reacceleration. Macroeconomic indicators—including inflation moderation and stabilizing interest rate expectations—are beginning to support a more constructive risk environment. GoldmanPeak reviews that these external factors, combined with improving liquidity and growing institutional engagement, could provide the catalyst for renewed directional momentum once confirmation levels are met.
Market structure data further suggests that volatility compression is reaching cyclical lows, a pattern historically associated with impending expansion phases. As algorithmic models detect strengthening momentum divergence and accumulation footprints, Bitcoin’s capacity to transition into a recovery trend becomes increasingly probable. GoldmanPeak reviews that traders are closely watching for volume confirmation and positive funding alignment—two metrics that often precede trend validation in maturing markets.
At a strategic level, the long-term outlook remains defined by convergence between technology, transparency, and adoption. The continued interplay between AI analytics, institutional frameworks, and risk-managed participation supports Bitcoin’s role as a structurally integrated financial asset. GoldmanPeak reviews that these forces collectively anchor Bitcoin’s evolution toward systemic relevance, where innovation and regulation coexist to sustain balanced market expansion.
Closing Statement
As liquidity strengthens and momentum indicators align, Bitcoin’s technical posture suggests the early signs of a structural rebound—marking a phase where analytical precision, transparency, and patience remain the defining traits of disciplined participation.
US500 Recovery on Imminent US Government Shutdown DealFundamental Analysis
The US500 is driven by strong Q3 earnings and a recovery in risk sentiment due to the imminent resolution of the US government shutdown. Market odds for a December Fed rate cut are high, boosting equity valuations. However, index gains are uneven, highly concentrated in the "Magnificent 7" tech mega-caps.
Technical Analysis
The index is in a well-defined upward channel, with dynamic support at the EMA 21. The RSI is bullish but nearing overbought territory, though all major moving averages signal a "buy." Short-term volatility (VIX) is low, supporting a continued grind higher. Key levels are 6,805 Support and 6,920 Resistance.
Sentiment Analysis
Optimism prevails following the drop in the VIX, indicating subsiding turbulence. Funds are positioning for a low-volatility climb. However, caution exists regarding high valuations in tech and signs of rotation into defensive sectors. Commentators view recent dips as routine corrections.
Outlook
The year-end target remains near 7,000, contingent on sustained macroeconomic stability and continued Fed dovishness. Pullbacks are expected to be buying opportunities given solid corporate profitability and continued AI enthusiasm. The core uptrend remains intact barring major policy or geopolitical surprises.
Analysis by Terence Hove, Senior Financial Market Strategist at Exness
Google Stock Approaches the $300 MarkGoogle’s stock has managed to remain near its all-time highs, and since its last major correction, it has posted a gain of more than 5% over recent trading sessions. However, the company’s recent comments regarding an increase in capital expenditures, projected to reach approximately $91 billion, have started to slow the stock’s upward momentum in the short term. This expansion in investment implies a greater financial commitment and a risk that expected revenue growth may not materialize. For now, buying pressure has entered a consolidation phase, which could lead to indecisive price movements in the coming sessions. Nonetheless, if the overall market bias remains bullish, this could support a gradual move toward the 300-dollar per share level.
Uptrend
Since late June, Google’s stock has maintained consistent upward movements, forming a rising trendline that has guided the price toward the $300 area. Despite the recent neutral phase, there are no significant bearish corrections threatening this trend, which continues to serve as the dominant technical structure in the short term. If buying pressure holds, the trendline could gain strength in the coming sessions. However, the recent lack of directional momentum also leaves room for potential short-term pullbacks.
RSI
The RSI indicator line shows dominant buying momentum, though it remains close to the overbought zone (around 70). Additionally, while the stock’s price has made higher highs, the RSI has formed lower highs, signaling a potential bearish divergence that could indicate an imbalance in market strength. This setup could lead to a short-term correction period in the coming sessions.
TRIX
The TRIX indicator remains above the neutral level of 0, suggesting that the average of exponential moving averages continues to show consistent buying strength. As long as the TRIX keeps rising, it could signal dominant buying pressure in the medium- to long-term trend.
Key Levels to Watch:
290 USD – Major Resistance: This level corresponds to the stock’s all-time highs and represents the most important bullish barrier to monitor. A breakout above this area could trigger a more aggressive short-term uptrend, potentially pushing the stock toward the psychological 300-dollar level, provided buying pressure remains dominant.
276 USD – Immediate Support: This level corresponds to the recent pullback zone and may serve as temporary support against short-term corrections.
257 USD – Key Support: This level coincides with both the uptrend line and the 50-period simple moving average. A break below this zone could endanger the current uptrend structure and give way to a new bearish bias of technical relevance.
Written by Julian Pineda, CFA, CMT – Market Analyst
Gold Latest Analysis and Trading Strategy:
I. Core Fundamental Drivers
Policy Expectations Support Gold Prices
Probability of a Fed rate cut in December has increased, boosting expectations for looser USD liquidity and enhancing gold's appeal.
The US government shutdown issue is nearing resolution; economic data will resume release, potentially amplifying market volatility.
Central Bank Gold Purchases Provide Long-Term Momentum
Global central banks continue to increase gold reserves: cumulative net purchases reached 634 tons in the first nine months of 2025, with China as the leading force.
The World Gold Council forecasts central bank purchases of 750-900 tons for 2025, with medium to long-term targets pointing towards $5000/oz.
Risk Warnings
If inflation remains persistently high, it could delay Fed rate cuts, triggering a risk asset adjustment and potentially putting short-term pressure on gold.
If the "tariff inflation" narrative fades after 2026, gold's upward momentum might weaken temporarily.
II. Key Technical Signals
Trend Structure
Breakout Confirmed: Wednesday's strong bullish candle broke through the key 4150 resistance, reaching a high of 4206, ending the consolidation phase and opening the door for further upside.
Multi-Timeframe Alignment: Daily and 4-hour moving averages are in a bullish alignment, indicating strong short-term momentum.
Critical Price Levels
Resistance Zones:
Short-term: 4200-4210 (4-hour upper Bollinger Band)
Core: 4250-4275 (0.786 Fibonacci retracement level)
Support Zones:
Primary: 4150 (Breakout confirmation/previous resistance turned support, key bull-bear line)
Strong Support: 4100 (Trend life-line)
Momentum Assessment
warranting caution for a technical pullback, but a secondary rally is expected after a dip to support zones.
Trend remains bullish as long as 4150 holds; a break below 4100 would shift the short-term outlook to neutral/consolidation.
III. Comprehensive Trading Strategy
Long Position Setup
Entry Timing:
Aggressive: Light long position on a pullback to 4160-4170.
Cautious: Add to longs near 4150 upon signs of stabilization.
Stop Loss: Place below 4140 (to guard against a false breakout).
Target Zones: 4230-4250, extend to 4275 upon a clear break above.
Short Position Defense (Counter-Trend)
Entry Timing:
Light short position on the first test of the 4250-4260 resistance area.
Stop Loss: Place above 4270.
Target Zones: 4200-4190, extend to 4170 upon a break lower.
IV. Risk Control & Execution
Position Management
Main strategy is to go long on pullbacks; short positions are only for light testing at resistance areas.
Keep risk per trade below 5% of capital; avoid holding losing positions against the trend.
Event Monitoring
Focus on US economic data releases , Fed official speeches, and US budget developments.
If rate cut expectations strengthen, consider raising long targets; if inflation exceeds expectations, be wary of a pullback towards 4100.
V. Summary
Trading Logic: Look to buy on dips in line with the trend, consider light shorts at resistance zones, and enforce strict risk control.
Medium to Long-Term Outlook: The combination of central bank buying and the potential Fed easing cycle suggests gold has potential to move towards $5000/oz, but be cautious of periodic adjustment risks.
Disney Is Up Just 4% YTD. What Its Chart Says Ahead of EarningsWalt Disney Co. NYSE:DIS plans to release fiscal Q4 results this week at a time when the stock has risen just 4% this year and trails the S&P 500 SP:SPX in timeframes ranging from three months to five years. Let's see what the entertainment giant's chart and fundamental analysis say.
Disney's Fundamental Analysis
The "House of Mouse" plans to roll out results ahead of the opening bell on Thursday for the three months ended roughly Sept. 30.
Wall Street expects DIS to report an adjusted $0.85 per fully diluted share on about $22.8 billion of revenue for the period. That would represent a 25.4% drop from the $1.14 in adjusted EPS the company earned in the same period last year, while revenue would have grown 0.9% from the $22.6 billion DIS recorded in fiscal Q4 2024.
In fact, only three of the 22 sell-side analysts that I know of that cover Disney have revised their earnings estimates higher since the quarter began, while 13 have cut their numbers. (The remaining six analysts made no changes.)
But beyond analysts, many economists will also be watching Disney's earnings for signs of the U.S. consumer's financial health.
After all, Disney's results could serve as an economic bellwether given that consumers might splurge on the company's theme parks and movies -- or skip them altogether depending on someone's individual finances.
So far, signs for the overall leisure-and-hospitality sector aren't all that encouraging, with the most recent employment reports showing decreased labor demand across the segment.
Disney's Technical Analysis
Now check out Disney's chart going back some five months and running through Friday afternoon:
Readers will first note that DIS peaked early this summer, creating a double-top pattern of bearish reversal marked with a jagged red line and red box at left above.
The stock then went into a long falling-wedge pattern, marked with blue diagonal lines and a blue box in the chart's center and right. This is considered a pattern of bullish reversal, but the falling wedge's two trendlines appear to be coming together only very slowly.
As Disney shares have worked their way lower over the past 4+ months, the stock has appeared to hit resistance at its 50-day Simple Moving Average (or "SMA," denoted by a squiggly blue line). However, the stock seems to have also found support at Disney's 200-day SMA (the red squiggly line above).
Looking at the secondary technical indicators that I most often follow, Disney's Relative Strength Index (the gray line at the chart's top) has been weak, but continues to work its way towards something closer to neutral.
Meanwhile, the stock's daily Moving Average Convergence Divergence indicator (or "MACD," marked with black and gold lines and blue bars at the chart's bottom), isn't saying much at all. The histogram of the stock's 9-day Exponential Average (or "EMA," marked with blue bars) seems to be sitting very close to zero and never straying very far.
Similarly, Disney's 12-day EMA (the black line) and 26-day EMA (the gold line) appear to be running together. The bulls would be rooting for the black line to overtake the gold line, but the fact that it hasn't (and that both of them are running below zero) is mildly bearish.
An Options Option
As I write this, the options market looks to be pricing in an approximate 7% move for Disney's stock following its upcoming earnings.
Options traders with no directional bias might employ what's called a "short strangle" in this scenario because they're hoping to take advantage of so-called "intrinsic-value crush (or "IV crush").
These traders are selling potentially unlimited risk for a premium, and are willing to take a short or long equity position should the stock move more than expected. Here's an example:
-- Sell (write) one DIS $119 call with a Nov. 14 expiration date (i.e., after this week's earnings come out). This was priced at about $1.36 as I wrote this column.
--- Sell (write) one DIS Nov. 14 $103 put for roughly $1.33.
Net Credit: $2.69.
This example has three potential outcomes at expiration:
-- Should the stock's price end up between $103 and $119 at expiration, the trader would simply pocket the $2.69 net credit.
-- Should Disney trade above $119 at expiration, the trader would end up short 100 DIS shares at a $121.69 net basis.
-- Should the stock trade at or below $103 at expiration, the trader would end up long 100 DIS shares at a $100.31 net basis.
(Moomoo Technologies Inc. Markets Commentator Stephen "Sarge" Guilfoyle had no position in DIS at the time of writing this column.)
This article discusses technical analysis, other approaches, including fundamental analysis, may offer very different views. The examples provided are for illustrative purposes only and are not intended to be reflective of the results you can expect to achieve. Specific security charts used are for illustrative purposes only and are not a recommendation, offer to sell, or a solicitation of an offer to buy any security. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. This content is also not a research report and is not intended to serve as the basis for any investment decision. The information contained in this article does not purport to be a complete description of the securities, markets, or developments referred to in this material. Moomoo and its affiliates make no representation or warranty as to the article's adequacy, completeness, accuracy or timeliness for any particular purpose of the above content. Furthermore, there is no guarantee that any statements, estimates, price targets, opinions or forecasts provided herein will prove to be correct.
Options trading is risky and not appropriate for everyone. Read the Options Disclosure Document ( j.moomoo.com ) before trading. Options are complex and you may quickly lose the entire investment. Supporting docs for any claims will be furnished upon request.
Options trading subject to eligibility requirements. Strategies available will depend on options level approved.
Maximum potential loss and profit for options are calculated based on the single leg or an entire multi-leg trade remaining intact until expiration with no option contracts being exercised or assigned. These figures do not account for a portion of a multi-leg strategy being changed or removed or the trader assuming a short or long position in the underlying stock at or before expiration. Therefore, it is possible to lose more than the theoretical max loss of a strategy.
Moomoo is a financial information and trading app offered by Moomoo Technologies Inc. In the U.S., investment products and services on Moomoo are offered by Moomoo Financial Inc., Member FINRA/SIPC.
TradingView is an independent third party not affiliated with Moomoo Financial Inc., Moomoo Technologies Inc., or its affiliates. Moomoo Financial Inc. and its affiliates do not endorse, represent or warrant the completeness and accuracy of the data and information available on the TradingView platform and are not responsible for any services provided by the third-party platform.
$SPOT Earnings Report and Technical Analysis OverviewSPOT Delayed Earnings Move
Earnings Report Summary
On the morning of November 4, 2025, Spotify Technology S.A. (SPOT) announced its earnings results for the third quarter, surpassing market expectations. The company reported earnings of $3.83 per share, notably higher than the consensus estimate of $1.87 per share. Revenue reached $4.99 billion, beating the expected $4.89 billion. This represented a 104.81% outperformance on earnings and a 13.93% increase in revenue year-over-year, with earnings growth at 140.9%. Despite this strong performance, Spotify provided guidance for fourth quarter revenue at approximately $5.17 billion, which is below the current consensus estimate of $5.32 billion for the period ending December 31, 2025.
Technical Analysis
Since mid-September, SPOT shares have been in a downtrend. A downward line of resistance had been identified, and as of today, the stock has broken above it. This movement also appears to form an undercut and rally pattern. However, several technical hurdles remain. Notably, the stock has not yet established a higher low or a higher high, which are key signals needed to confirm a reversal of the downtrend. Additionally, SPOT is currently trading below its 21-day exponential moving average (EMA), 50-day moving average (DMA), and 200-day moving average (DMA).
Criteria for Reversal Confirmation
While there are signs that a reversal may be underway, further evidence is required. The first indication would be the formation of a higher low, suggesting some retracement without returning to recent lows. Following this, the stock would need to move above both the 21 EMA and 200 DMA. Should these milestones be reached, it could present a favorable risk-reward trading opportunity, with a stop loss placed just below the most recent established low.
Investment Considerations
SPOT may be worth adding to your watchlist, though the current setup does not yet meet the criteria for action under this trading strategy. It is important for readers to conduct their own analysis and consistently apply personal trading rules. All investments involve risk, and informed decision-making is essential when committing capital.
GOLD volatility, monetary policy and political riskThe global OANDA:XAUUSD went through a volatile trading session on Tuesday, as prices fell more than $50 in the North American session before recovering around $30, ending the day in the green. As of Wednesday morning, November 12, spot gold stood at around $4,128/ounce, up around $2 on the day.
The main drivers of this development came from two opposing factors: the prospect of the Federal Reserve (Fed) possibly cutting interest rates in December, and capital withdrawals from gold ETFs after a long rally.
Policy pressures and labor market signals
U.S. private payrolls data, according to preliminary estimates from ADP Research, showed a weekly average of 11,250 job cuts in the four weeks ended October 25. The weaker-than-expected figure sent the dollar to a low of 99.29, giving gold a chance to rebound.
The move comes just as Washington is about to end its longest government shutdown in history, which has stalled the release of economic data. Investors are hoping the reopening of the government will quickly bring a wave of pent-up data that will help better determine the true state of the U.S. economy.
“As the government reopens, we’re going to start seeing more cracks in the economy,” said Marc Chandler, chief strategist at Bannockburn Global Forex. This expectation reinforces the belief that the Fed will begin its easing cycle in December. According to the CME FedWatch tool, the probability of a rate cut has risen to 64%, while Fed Governor Milan hinted at the possibility of a 50 basis point cut due to a weak labor market and slowing inflation.
ETF Profit Taking, Gold Temporarily Adjusts
However, gold’s rally was capped by profit-taking in the ETF market. Bloomberg data shows gold ETFs have seen four straight weeks of outflows, after eight weeks of net buying. “Every 1% move in the gold price translates into about 10 tonnes of ETF outflows,” said Michael Haigh, head of FIC research at Société Générale.
The reversal reflects investors’ defensive sentiment after gold peaked at $4,380 an ounce in mid-October, a new record high amid political uncertainty and expectations of lower interest rates. Still, safe-haven demand was strong enough to help prices recover to $4,126.77 by the end of Tuesday’s session, up 0.3%.
US Politics: A lull ahead of data
The US Senate has passed a deal to reopen the government, while the Republican-controlled House is expected to approve it this week, before it goes to the White House for President Trump to sign into law. The reopening of the government not only ends the government shutdown but also sets the stage for a new cycle of data releases, including official jobs and inflation reports.
Medium-term outlook: Gold demand remains strong
Despite short-term volatility, fundamentals remain supportive of gold. The precious metal has risen more than 55% year-to-date, on track for its biggest gain since 1979. “The medium-term support from global easing to central bank demand remains intact,” said Christopher Wong, a strategist at OCBC.
Summary
The gold market is operating in a cycle of monetary policy expectations and geopolitical safe-haven sentiment. As the Fed moves closer to easing and delayed data looms, price volatility is likely to remain high.
However, with sustained central bank buying and global risks remaining intact, gold remains a strategic asset in a reshaping global financial landscape.
Technical analysis OANDA:XAUUSD
Gold prices are maintaining a short-term uptrend channel formed from the October bottom. After a deep correction around $3,970 – $3,850/ounce (corresponding to the Fibonacci levels of 0.382 and 0.5), the price has bounced back and is currently trading around $4,123, close to the technical resistance zone of Fib 0.236 at $4,128.
The moving average (MA21) is currently at $4,055, acting as a dynamic support zone in the short term. The recent candlestick structure shows that the bullish momentum is being consolidated with a series of higher lows, while the RSI has recovered towards 55, confirming that the bullish momentum is regaining the upper hand.
If gold holds above the $4,055 zone, the next upside targets are:
• Near resistance: $4,216 – $4,220 (psychological level and 0.236 Fibonacci resistance zone).
• Extended resistance: $4,308 – $4,380 (historic old peak zone).
On the contrary, if the price loses $4,055, the $3,972 – $3,846 zone will become the main support zone to watch, corresponding to the lower boundary of the current uptrend channel.
The overall trend remains bullish, provided the $4,055 support zone holds. The current phase is a recovery accumulation phase, which could open up a further rally towards $4,300 if US economic data continues to be weak and the Fed reinforces easing expectations.
SELL XAUUSD PRICE 4201 - 4199⚡️
↠↠ Stop Loss 4205
→Take Profit 1 4193
↨
→Take Profit 2 4187
BUY XAUUSD PRICE 4090 - 4092⚡️
↠↠ Stop Loss 4086
→Take Profit 1 4098
↨
→Take Profit 2 4105
NAS100 (NASDAQ 100) Long Signal Analysis🟢 NAS100 (NASDAQ 100) Long Signal Analysis
📈 Entry Zone: 25,409
🎯 Targets: 25,620 – 25,740 – 25,887 (Final Target)
❌ Stop Loss: 25,280
Analysis:
NAS100 is showing renewed bullish momentum after finding support near the 25,400 zone. Price action suggests buyers are stepping back in following a brief pullback, with higher lows forming on lower timeframes — a strong sign of accumulation.
If the index sustains above 25,400, momentum could push prices toward the 25,887 zone. Positive structure and improving volume support the long bias, with potential continuation as long as the price remains above the short-term moving average and key support level.
💡 A confirmed candle close above 25,500 would further validate bullish continuation. A break below 25,280 may invalidate the setup.
⚠️ This analysis is shared purely for educational and informational purposes — not financial advice. Always manage risk and confirm entry with your own analysis..
GLUE jumped 191% with 93% score on the indicator almost perfectHi guys,
A stock that jumped in the daily scan of the indicator and could be very interesting right now.
It received a score of 93 percent and therefore caught the eye like fire. My indicator is simply enthusiastic about it - it sees an almost perfect setup for momentum there.
It has a near-perfect stop and the third quarter 2025 reports were released this morning before the open. These reports can move the stock in either direction, so I recommend waiting to see the market's reaction and then perhaps considering an entry. I personally will not enter until I see that the market has digested the reports.
About the company:
Monte Rosa Therapeutics is a relatively small company from Boston that was founded only in 2019, but it is doing something really special. They have developed an innovative technology called Molecular Glue Degraders (MGD for short). It's basically a type of small drug that uses the body's natural mechanisms to break down proteins that cause disease instead of just blocking them.
Their secret engine is called QuEEN and uses artificial intelligence to identify proteins that can be broken down and design precision drugs. It's a technology that's considered revolutionary in the industry because it can treat diseases that no other drug has been able to treat.
The company is currently developing three main drugs in parallel. MRT-2359 to treat cancers driven by the MYC protein (including hard-to-treat prostate cancer), MRT-6160 for autoimmune and inflammatory diseases like lupus, and MRT-8102 for inflammatory diseases related to the NLRP3 mechanism. The first drug is already in advanced clinical stages with promising results, and the other two are in the early stages of human testing.
Institutional investors and large banks believe in this company. They have 10 analyst coverage and the majority of the average is BUY with an average target price of $13.50, which is another increase of almost 110 percent from the current price.
Massive Collaborations:
This is the interesting part. Last September, they announced a second collaboration with Novartis, one of the largest pharmaceutical companies in the world. In this agreement, Novartis paid them $120 million immediately in cash, and there is another potential of $5.7 billion if they meet all the milestones.
This is in addition to the first agreement they already had with Novartis in October 2024 for the drug MRT-6160, where they received $150 million upfront and up to an additional $2.1 billion in milestones. In total, there is a potential of almost $8 billion from the two agreements with Novartis alone.
They also have a collaboration with Roche to research and develop additional drugs in the field of cancer and neurological diseases. This shows that their technology is of interest to the big players in the industry.
Latest news:
Last week, the company presented strong preclinical data on MRT-6160 at the ACR Convergence 2025 conference, showing that the drug degrades more than 90 percent of the VAV1 protein and significantly inhibits the function of T and B cells. This is important because VAV1 is involved in many autoimmune diseases.
A few weeks ago, they announced that they would be attending four investor conferences in November-December 2025, including at Guggenheim Healthcare in Boston, TD Cowen Immunology Summit, Jefferies Global Healthcare in London, and Piper Sandler in New York. This means that they want to promote their story to big investors.
In March 2025, they presented exciting results from the clinical study of MRT-2359 in patients with castration-resistant prostate cancer (CRPC). Of the three patients treated, one achieved a confirmed partial response (PR) and two achieved stable disease (SD). Interestingly, all three patients had mutations that link resistance to standard treatments. In one of them, PSA levels dropped by 90 percent and the tumor shrank by 57 percent. As a result, they plan to expand the study to 20-30 more patients.
In July 2025, they began dosing the first people in a phase 1 study of MRT-8102 (the anti-inflammatory drug) with results expected in the first half of 2026.
In their second-quarter 2025 financial statements released in August, they reported revenue from collaborations of $23.2 million, a huge jump from $4.7 million in the same quarter last year. Their net loss fell from $30.3 million to $12.3 million. They have $295.5 million in cash that should fund operations through 2028.
In the fourth quarter of 2024 (reported in March 2025) they reported a colossal $60.6 million in revenue from collaborations and $38.9 million in R&D expenses.
Technical View:
Technically, the stock was at an ATH of around $44 in September 2021 and then crashed to $3.50 in August 2025. Since then, it has been on a strong rise and has already climbed to $13.22, a 191% increase in three months.
It is now at $12.31 in a three-day consolidation in the range of 11.50-13.22. The price is above the EMA10 at 11.9 and above the SMA200 at 5.88. There is a Perfect Order of all moving averages here and they are rising at a slope of 24.34 percent - this is a Strong Uptrend.
The average volume is 1.13 million shares per day and the ADR (average daily volatility) is 7.61 percent. The RSI is at 68.3 which is still normal and not overbought. The performance ratio compared to the S&P 500 is 181.93 percent - the stock is simply driving the market crazy.
In the last 10 days there have been 6 Higher Highs and 6 Higher Lows, this is a classic and clean uptrend.
There are currently no distribution signs or warnings on the chart. This is a Setup looking Ready for a breakout.
Weekly Trend:
Here I have one comment - in the weekly view the trend is still Neutral. This means that although the stock has made a strong increase in recent months, it has not yet clearly broken above significant resistance levels on the week. This should be taken into account.
*Sentiment and Social Networks:
I searched StockTweets and Reddit and saw that there are discussions, but they are not super active. This is not a stock that is talked about a lot on the networks or social media.
The main investors here are institutional rather than retail traders. The sentiment on StockTweets seems neutral to slightly positive but there is not a lot of activity there.
The analysts and experts are actually very positive. There are 9 companies with an Outperform or Buy recommendation, an average of 1.8 (scale of 1 to 5).
The risks:
This is still a clinical-stage biotech company without sales of real drugs. All the drugs are still in development and they have to go through the regulatory processes. If one of the clinical trials fails, the stock could collapse. Their cash is only supposed to last until 2028 and if they don't get more money from Novartis or other investors, they will have to raise capital.
The biotech sector is one of the most volatile and risky sectors. Most companies at this stage fail. The stock's beta is 1.53, which means it is 50 percent more volatile than the market.
It should be noted that the M-Score (financial manipulation indicator) has a score of 23.4 which could indicate a warning, but this is common in biotech companies at this stage because there is a lot of fluctuation in revenue from collaborations.
In conclusion:
I'll wait for the report.
My method is always to wait for large volume in the pre-market, which is at least 1.5 times and preferably the average volume, and then use my ORB indicator to get additional confirmation in the first 5 minutes of the open; but since they have reports coming out and I still don't know if it'll be far enough to cause a commotion in the pre market I'll wait.
This is a stock that my indicator really likes technically - it has a Perfect Order, strong momentum, and a clean setup. Fundamentally it has innovative technology, collaborations with giant pharmaceutical companies, promising clinical data, and good cash for several years.
But this is biotech with all the risks that come with that. The reports came out this morning and the current price of $12.31 already embodies some of the expectations. I personally wouldn't enter now before seeing the market's reaction to the reports and maybe wait for a small pullback to the 11-11.50 area where there is support. If it breaks 13.48 on high volume then you could consider entering with a very short stop loss below 11.84.
Definitely a stock to watch, but with great caution.
Just before you jump in:
Listen, I'm not an investment advisor and I don't want to be one. What I've written here is simply my analysis with the indicator I developed, and it could be completely wrong.
Biotechnology is not a game - it's one of the riskiest sectors there is. Ninety percent of clinical-stage companies fail and the money goes down the drain. You could lose everything.
I **do** not own this stock now and **will** not enter before I see what happens with the reports that came out today . I don't know you, I don't know the state of your portfolio, and I don't know how much risk you can take.
Before you put money in - do your homework, talk to someone professional who knows you, and only then decide. And don't invest money that you need for your electric bill.
Good luck to all of us, and may the goddesses shower us with an abundance of money.
Long trade
1hr TF overview
📘 Trade Journal Entry
Pair: ETHUSDT.P (Perpetual Contract)
Date: Wed 12th Nov 2025
Time: 7:00 AM
Session: London to New York Session AM
Direction: Buyside Trade
Timeframe: 15-Minute
🔹 Trade Details
Entry: 3552.98
Profit Level (TP): 3807.27 (+7.17%)
Stop Level (SL): 3530.45 (–0.63%)
Risk-Reward Ratio (RR): 11.31
🔹 Technical Context
Market Structure:
🧾Prior Consolidation Phase at top range followed by a significant markdown breaking below structural support.
🧾The secondary retest formed at the base level (3244–3200 zone) aligned with liquidity grab beneath prior lows (PDL).
🧾Subsequent shift in structure (CHOCH → BOS) on the 15M chart suggests transition from distribution to early accumulation.
Key Confluences:
🧩Fair Value Gaps (FVGs) identified within the 0.75–0.25 retracement zone, acting as re-entry and mitigation areas.
🧩Breaker Block formation confirmed following BOS, validating bullish continuation setup.
🧩Volume expansion visible around 3550 region, signalling strong buy-side interest.
🧩Kaufman Adaptive Moving Average (KAMA) providing dynamic trend support near 3475 level.
📈Target Narrative:
We assume that price aims to rebalance inefficiency toward the 3,800–3,850 liquidity zone, corresponding to prior unmitigated FVG and institutional range midpoint.
🔹 Narrative & Sentiment
The setup reflects a buyside re-accumulation model emerging from deep discount levels post-sell climax. The corrective structure within the descending wedge aligns with the Wyckoff “Spring” and “Test” phase, suggesting smart money re-entry before expansion.
Macro sentiment also supports ETH strength into mid-November amid rotational flow from BTC dominance cooldown and speculative positioning ahead of CPI data.
BFLY — Butterfly Network Inc. | August 27, 2025.NYSE:BFLY #BFLY — Butterfly Network Inc. (NYSE:BFLY) | Healthcare | Medical Devices | USA | NYSE | August 27, 2025.
Executive Summary
Butterfly Network Inc. (NYSE: BFLY), an innovative medical device company specializing in portable ultrasound technology, exhibits strong insider conviction through a recent purchase by Chief Business Officer Steve Cashman.
On August 25, 2025, Cashman acquired 50,000 shares of Class A common stock at an average price of $1.64 per share, totaling $81,953 in value. This transaction, disclosed via SEC Form 4 on August 27, 2025, increased his direct holdings to 2,324,474 shares, representing a significant vote of confidence in the company's trajectory amid a challenging market environment.
Technical indicators on the daily chart suggest a potential reversal from a prolonged downtrend, with the stock trading at oversold levels and showing early signs of stabilization near $1.57. Q2 2025 financials reported record revenue of $23.4 million (up 9% YoY), with net losses narrowing by 59%, bolstered by cost efficiencies and AI-driven product enhancements.
Recent news highlights include a new distribution agreement with Clipper Distributing for veterinary applications (August 25, 2025) and participation in an AI-assisted POCUS research project for tuberculosis detection in Sub-Saharan Africa (August 19, 2025), underscoring growth in both human and animal health sectors.
Replicating Cashman's buy at approximately $1.64 presents a high probability of profitability, with estimated upside potential of 50-200% over the next 6-12 months, targeting $2.50-$5.00. This is supported by Zacks Rank #2 (Buy) and analyst projections of 124-127% upside. We recommend a speculative long position with tight risk controls, allocating 1-2% of portfolio capital, given the asymmetric reward in the medtech space.
Company Profile
Butterfly Network Inc. (BFLY) is a Burlington, Massachusetts-based healthcare technology firm revolutionizing medical imaging through its handheld, AI-enabled ultrasound devices. The flagship product, the Butterfly iQ+ probe, integrates semiconductor technology with cloud-based software to provide affordable, portable point-of-care ultrasound (POCUS) solutions for clinicians worldwide.
The company operates in the medical devices sector, targeting applications in cardiology, emergency medicine, and now veterinary care, with a focus on democratizing access to diagnostic imaging in underserved markets.
Key financial metrics as of August 27, 2025:
• Market Capitalization: $395.24 million
• Enterprise Value: $268.75 million (approx.)
• Price-to-Sales (TTM): 4.52
• Price-to-Book (MRQ): 1.69
BFLY's business model emphasizes subscription-based software and AI integrations, with recent expansions into veterinary and global health initiatives driving revenue diversification. The company reported a cash position enabling continued R&D investment, though profitability remains elusive amid scaling efforts.
Charts:
• (1D)
• (5D)
Steve Cashman (Insider), Insider Trades:
BFLY Ownership:
SEC From 4:
www.sec.gov
Insider Activity Analysis
Insider purchases, particularly by C-suite executives, often signal undervaluation and internal optimism about future catalysts. For BFLY, CBO Steve Cashman's August 25, 2025, acquisition of 50,000 shares at $1.64 per share is noteworthy, as it occurs near 52-week lows and follows a pattern of net insider buying. Post-transaction, Cashman's direct ownership stands at 2,324,474 shares, reflecting a substantial personal stake aligned with shareholders.
Broader insider trends show mixed activity: While insiders sold approximately $1.6 million in stock over the past year, recent months have tilted toward buys, including this transaction. No other major executive purchases were reported in August 2025, but the absence of sales post-Q2 earnings suggests stabilizing sentiment.
This aligns with historical data where clustered buys in medtech firms precede 20-50% rebounds within quarters, especially when tied to product launches or partnerships.
Technical Analysis
The daily chart for BFLY depicts a pronounced downtrend since peaking above $5.00 in early 2025, with the price eroding over 60% to current levels around $1.57 amid broader healthcare sector pressures. Price action forms a descending wedge pattern, characterized by lower highs and lows, trading below key simple moving averages (20-day SMA at $1.74, 50-day at $2.50, 200-day at $2.81), confirming bearish momentum.
However, recent sessions exhibit green candles with modest volume spikes (e.g., 1.44M shares on August 27), hinting at accumulation.
Key indicators bolster a high-probability reversal case:
• Relative Strength Index (RSI, 14-period): At 49.65 on the primary chart (neutral) and 38.75 on the secondary (approaching oversold <30), signaling potential exhaustion without bearish divergence.
• Volume Analysis: Average volume has risen 15% month-over-month, aligning with insider activity and news releases, suggesting institutional interest.
• Support and Resistance: Immediate support at $1.50 (recent swing low) and $1.21 (52-week low). Resistance at $1.80 (near-term pivot), $2.50 (50-day SMA), and $3.00 (prior consolidation zone).
• Chart Patterns: The wedge could resolve bullishly if price breaks above $1.80 on volume, targeting a measured move to $3.00+. Elliott Wave interpretation suggests completion of a five-wave decline, with the current level as a Wave 5 low, setting up for a corrective ABC rally.
Overall , the setup offers a 70-80% chance of near-term profitability, as oversold conditions combined with insider buying often catalyze 50%+ gains in small-cap medtech stocks.
Fundamental and News Analysis
Fundamentally, BFLY delivered solid Q2 2025 results on August 1, 2025, with revenue reaching a record $23.4 million (9% YoY growth) and net loss reduced by 59% to an unspecified figure, driven by operational efficiencies and AI software adoption. Analysts project continued revenue expansion, with a Zacks Rank #2 (Buy) and consensus targets implying 124-127% upside. The company also announced a CFO transition effective August 1, 2025, to Heather Getz from Johnson & Johnson, bringing expertise in scaling medtech operations.
Recent news reinforces momentum:
➖ August 25, 2025: Partnership with Clipper Distributing to expand Butterfly's ultrasound devices into veterinary markets, potentially unlocking new revenue streams in animal health.
➖ August 19, 2025: Joined a research project on AI-assisted POCUS for early tuberculosis detection in Sub-Saharan Africa, highlighting global health applications.
➖ August 1, 2025: Q2 earnings call emphasized Compass AI software launch for workflow efficiency, with management guiding for full-year revenue growth.
Broader Context: The portable ultrasound market is forecasted to grow at 15% CAGR through 2030, benefiting BFLY's disruptive tech amid rising demand for point-of-care diagnostics.
Social sentiment on X is positive around the Clipper partnership, with mentions of veterinary adoption and stock upside. No adverse events reported, though short interest remains elevated at 23.55% as of August 22, 2025.
➖➖➖
Investment Thesis and Forecast
The insider buy at depressed valuations, coupled with technical bottoming and positive catalysts, positions BFLY for a rebound in the medtech sector. Replicating Cashman's entry at $1.64 yields the following scenario:
Entry Price: $1.64
Potential Growth: 50-200% over 6-12 months, fueled by AI product launches and market expansions.
Exit Targets:
➖ Conservative (Target 1): $2.50 (52% profit, +$0.86/share) – Exit at 50-day SMA or post-partnership revenue updates.
➖ Moderate (Target 2): $3.50 (113% profit, +$1.86/share) – Scale out 50% on RSI >70 or analyst upgrades.
➖ Aggressive (Target 3): $5.00 (205% profit, +$3.36/share) – Full exit on breakout above $4.00 or M&A speculation.
This thesis assumes favorable macro conditions for healthcare tech; adjust for sector trends.
Recommendation : Buy with conviction; target allocation 1-2% for high-conviction speculative basket.
Disclaimer : This report is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
GOLD GOES " ̶T̶R̶I̶P̶L̶E̶ ̶V̶O̶D̶K̶A̶" TRIPLE TOP PATTERNGold has recently exhibited strong technical momentum, rebounding from its $3,900 support and surpassing the 50-day moving average, which marks a bullish reversal after a late-October dip.
Immediate support is at $4100 per ounce.
The Relative Strength Index (RSI) is rising, confirming buyers have regained control in the short-term and signaling the possibility for further upside.
BUY THE DIP SCENARIO
Current trading strategies suggest buying near support and targeting resistance upward, demonstrating an underlying “buy on dips” scenario as gold consolidates above $4100.
WHAT IS " ̶T̶R̶I̶P̶L̶E̶ ̶V̶O̶D̶K̶A̶" TRIPLE TOP PATTERN
The triple top pattern is a bearish reversal technical chart pattern signaling the potential end of an uptrend and the beginning of a downtrend.
It forms after an asset price hits the same resistance level three times but fails to break above it, creating three distinct peaks at roughly the same price level. Between these peaks are pullbacks or troughs, forming support levels. The pattern is confirmed only when the price breaks below the support (neckline) formed by these troughs.
The psychology behind this pattern shows weakening buying power as the price fails to surpass the resistance level on three attempts. Each peak typically has declining volume, reflecting decreased buying enthusiasm. After the third peak, sellers could gain control, and the price could falls below support with increased volume, confirming the reversal.
CONCLUSION
Traders use the triple top to anticipate the exhaustion of bullish momentum, signaling caution and opportunities to enter short positions or exit longs.
The pattern reflects supply overwhelming demand after repeated failed rallies, indicating a shift from bullish to bearish sentiment. It is considered a reliable indicator after a sustained uptrend and is used with risk management strategies to navigate market turns effectively.
TECHNICAL SUMMARY
Just simply take a look at history of Gold. It says: " ̶T̶R̶I̶P̶L̶E̶ ̶V̶O̶D̶K̶A̶" TRIPLE TOP.
--
Best wishes,
@PandorraResearch Team






















